Newsroom

Eko Brings Cardiopulmonary Focus to the Frontline of Care With the Next Generation DUO

The pocket-sized cardiac examination system helps clinicians of all types detect heart disease earlier.

August 16, 2021

Articles

Eko Brings Cardiopulmonary Focus to the Frontline of Care With the Next Generation DUO

The pocket-sized cardiac examination system helps clinicians of all types detect heart disease earlier.

Eko Appoints Renee Gaeta as Chief Financial Officer

Gaeta, a seasoned medical technology executive joins the company as it continues its product and healthcare market expansion

HRS and Eko Announce Partnership

Health Recovery Solutions (HRS) and Eko Announce Partnership to Integrate Eko DUO ECG + Digital Stethoscope into HRS Telehealth Solution

Eko Supports Emergency Medical Services (EMS) in Partnership with National Association of Emergency Medical Technicians (NAEMT)

Eko announces that it has become a new corporate partner of the National Association of Emergency Medical Technicians (NAEMT).

Eko’s AI Analysis Algorithm Validated as a Clinical Tool for Detecting Heart Murmurs

Peer-reviewed publication in the Journal of the American Heart Association found the AI algorithm detects clinically significant murmurs comparable to expert cardiologists

Eko Recognized for Artificial Intelligence Innovation in Healthcare with 2021 MedTech Breakthrough Awards

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

Eko Launches Eko Academy

App to Help Medical Students and Healthcare Providers Strengthen their Stethoscope Skills and Auscultation Knowledge

Eko Raises $65 Million in Series C Funding

Eko wants every patient with chronic cardiovascular disease to be one click away from their doctor.

3M™ Littmann® Stethoscopes and Eko announce new collaboration

Bringing together science, technology, and comprehensive solutions to redefine what’s possible in healthcare.

Eko Named to the 2020 CB Insights Digital Health 150

Eko recognized for achievements in AI-powered analysis of cardiopulmonary disease.

Eko Announces Global Collaboration with AstraZeneca

Development of integrated AI digital health solutions to help patients better manage their cardiovascular health.

Eko Receives $2.7 Million Grant from NIH

NIH Awards Eko $2.7M for clinical study on valvular heart disease detection.

Eko Appoints Bryan Humbarger as New Commercial Leader

Eko appoints new commercial leader.

Eko Launches Telehealth Platform

The First AI-Powered telehealth platform for virtual pulmonary and cardiac exams.

FDA Issues Emergency Use Authorization for Eko's Low Ejection Fraction Screening Algorithm

During COVID-19, FDA Issues Emergency Use Authorization for algorithm designed to improve detection of heart failure.

Eko Named to the 2020 CB Insights AI 100 List

Eko Named to the 2020 CB Insights AI 100.

Eko Appoints Dr. Adam Saltman as Chief Medical Officer

Former FDA Medical Officer joins Eko as Chief Medical Officer.

FDA Clears Eko's AFib and Heart Mumur Detection Algorithms

Eko’s algorithms alert clinicians to the presence of heart murmurs and atrial fibrillation (AFib) during the physical exam.

FDA Grants 'Breakthrough' Designation to Eko's Low Ejection Fraction Algorithm

FDA Grants ‘Breakthrough’ designation to Eko’s Low Ejection Fraction screening algorithm.

Eko and Mayo Clinic use ECG-Enabled Stethoscope to Effectively Detect Heart Failure

Eko and Mayo Clinic use ECG stethoscope DUO to effectively detect heart failure.

Eko Closes $20M in Series B

Eko closes $20M in Series B led by ARTIS Ventures.

Eko Announced as Finalist for UCSF Digital Health Awards

Eko announced as finalist for UCSF Digital Health Awards.

Eko Collaborates with Mayo Clinic on a Machine Learning-Based Algorithm

Eko Collaborates with Mayo Clinic on a machine learning-based algorithm.

Eko Closes $5M Series A

Eko closes $5M Series A led by ARTIS Ventures.